The MarketWatch News Department was not involved in the creation of this content.-- This marks the first live procedure at AAHS, as well as a first for Keenova. -- Treatment takes ...
This is the first part of a three-part interview from Broncos Wire's Brandon Walker with Pro Football Hall of Fame quarterback John Elway. This first story focuses on Elway's diagnosis of Dupuytren's ...
This week, we are going to discuss a hand condition that is quite problematic and can be very limiting for patients suffering from this condition – Dupuytren’s contracture. Dupuytren’s contracture is ...
MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his ...
A local guitarist couldn't play without pain until he discovered a non-invasive procedure using low-dose radiation therapy.
Hall of Fame quarterback John Elway was recently seen on NBC's "Today" show to talk about the debilitating hand condition he has been battling for 15 years -- Dupuytren's contracture. When the former ...
ROCKVILLE, Md. The Food and Drug Administration has approved a drug for treating a debilitating hand condition which affects an estimated 13.5 million to 27 million Caucasians in the United States and ...
Dupuytrens Contracture is a condition in which a person's fingers bend toward the palm and cannot be fully extended. The condition can make working, and even daily functioning, difficult. Dr. Tom ...
Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or CCH) will be shared at the American ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
In the coming months you may hear about a new drug for treating cellulite, called Xiaflex. The pharmaceutical manufacturer that makes it just began clinical trials of its effects in January. I am not ...